KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Price (Quote)

$1.23
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $1.23 $1.23 Friday, 27th May 2022 CTRV stock ended at $1.23. During the day the stock fluctuated 0% from a day low at $1.23 to a day high of $1.23.
90 days $0.94 $1.27
52 weeks $0.86 $2.32

Historical ContraVir Pharmaceuticals Inc prices

Date Open High Low Close Volume
Feb 29, 2016 $526.40 $532.00 $492.80 $492.80 20
Feb 26, 2016 $504.00 $526.40 $492.80 $515.20 46
Feb 25, 2016 $532.00 $540.40 $515.20 $526.40 37
Feb 24, 2016 $504.00 $548.80 $504.00 $548.80 41
Feb 23, 2016 $532.00 $554.40 $498.40 $504.00 155
Feb 22, 2016 $571.20 $571.20 $528.08 $537.60 41
Feb 19, 2016 $565.60 $616.00 $548.80 $554.40 174
Feb 18, 2016 $565.60 $588.00 $526.40 $582.40 72
Feb 17, 2016 $548.80 $571.20 $504.00 $560.00 75
Feb 16, 2016 $526.40 $554.40 $464.80 $537.60 63
Feb 12, 2016 $487.20 $532.00 $481.60 $498.40 91
Feb 11, 2016 $504.00 $504.00 $487.20 $492.80 98
Feb 10, 2016 $515.20 $551.04 $504.00 $509.60 41
Feb 09, 2016 $515.20 $560.00 $504.00 $504.00 82
Feb 08, 2016 $537.60 $571.20 $477.68 $532.00 100
Feb 05, 2016 $548.80 $571.20 $539.84 $548.80 69
Feb 04, 2016 $565.60 $571.20 $542.08 $571.20 38
Feb 03, 2016 $576.80 $576.80 $532.00 $565.60 78
Feb 02, 2016 $548.80 $593.60 $548.80 $571.20 131
Feb 01, 2016 $532.00 $604.80 $520.80 $554.40 88
Jan 29, 2016 $560.00 $607.60 $532.00 $532.00 238
Jan 28, 2016 $537.60 $616.00 $481.60 $560.00 469
Jan 27, 2016 $537.60 $556.08 $526.40 $532.00 56
Jan 26, 2016 $548.80 $560.00 $527.52 $537.60 59
Jan 25, 2016 $560.00 $588.00 $537.60 $554.40 134
Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT